Professor Mary Galea, AM FAHMS FACP, is a physiotherapist and neuroscientist whose research in basic and clinical neuroscience has contributed to understanding the organisation and development of the motor system and its recovery from injury following nervous system disorders such as spinal cord injury, stroke, and multiple sclerosis. She is Professorial Fellow in the Department of Medicine at the University of Melbourne, with Honorary appointments in the Department of Rehabilitation Medicine, Royal Melbourne Hospital and the Victorian Spinal Cord Service, Austin Health. She leads the Program in Restorative Neuroscience in the Graeme Clark Institute for Biomedical Engineering at the University of Melbourne. Her current major project is an early phase adaptive trial of transcutaneous spinal cord neuromodulation to improve hand function following spinal cord injury. Prof Galea is past Chair of the Stroke Association of Victoria, and member, Scientific Advisory Committee of SpinalCure Australia, and Clinical Governance and Research Committee of Spinal Cord Injuries Australia.

https://fi.linkedin.com/in/anastasiashulga

Siti Nurfaezah Binti Zahari completed her PhD in Biomedical Engineering at the University of Toronto, with a Collaborative Specialization in Neuromodulation, and conducted her doctoral research at the KITE Research Institute, Toronto Rehabilitation Institute – University Health Network. Her research focuses on the development and evaluation of an automated multi-dermatome computer-controlled electrical perceptual threshold (CCEPT) system for quantitative sensory assessment in individuals with spinal cord injury. Her work aims to improve the accuracy, consistency, and efficiency of sensory assessment and to support the clinical evaluation and monitoring of neurological function following spinal cord injury. Her broader research interests include neurotechnology, rehabilitation engineering, quantitative sensory assessment, neuromodulation, and data-driven approaches to spinal cord injury rehabilitation.

Ryo Ogaki, MD, PhD candidate, is an orthopaedic surgeon at Keio University School of Medicine, Japan. His research focuses on regenerative therapies for spinal cord injury, particularly chronic cervical SCI, using human iPSC-derived neural progenitor cells. He received the 1st Place Basic Science Award from the Cervical Spine Research Society (CSRS) in both 2024 and 2025.

Prof. Dr Jivko Stoyanov leads the SCI Population Biobanking and Translational Research Group at Swiss Paraplegic Research, Nottwil, and the Swiss Spinal Cord Injury Cohort Biobank. He is Titular Professor at the University of Bern. His research focuses on translational medicine, biomarker discovery, multi-omics, and precision rehabilitation in spinal cord injury.